Retinal ganglion cell (RGC) (RGC)

Retinal ganglion cells (RGCs) are the essential output neurons of the retina, responsible for relaying visual information from the eye to the brain via the optic nerve (StatPearls). These cells receive integrated visual inputs from photoreceptors through intermediate bipolar and amacrine cells and are the only retinal cells that transmit signals via action potentials (NIH). RGCs are distinguished by their long axons that converge at the optic disc to form the optic nerve. In clinical medicine, the progressive degeneration and apoptosis of these cells is the defining pathological feature of glaucoma, which is a leading cause of irreversible blindness worldwide (PubMed). While RGCs are a cell type and not a single molecular target, they represent a critical focus for neuroprotective drug development and regenerative medicine. Therapeutic strategies often involve lowering intraocular pressure using prostaglandin analogs like latanoprost or investigating direct neuroprotective agents such as brimonidine to preserve RGC viability (NIH). Monitoring RGC health in patients is typically performed using optical coherence tomography (OCT) to measure the thickness of the retinal nerve fiber layer (Wikipedia).

Other names

Ganglion cellRetinal ganglion neuronGanglion cell of retina

Drugs targeting Retinal ganglion cell health typically function by lowering intraocular pressure (IOP) to reduce mechanical stress or by providing direct neuroprotection through the modulation of alpha-2 adrenergic receptors, NMDA receptors, or survival signaling pathways (NIH, StatPearls).